2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cancer genetics<br />
way consists <strong>of</strong> three major components: the nuclear core complex<br />
composed <strong>of</strong> at least eight FA proteins (group 1), which activates the<br />
“group 2” proteins FANCD2 and FANCI (ID complex) . The ID complex<br />
is then targeted to chromatin and co-localizes with “effector” proteins<br />
such as BRCA2 or RAD51 (group 3) . Recent progress in understanding<br />
the FA/BRCA network was achieved by the discoveries <strong>of</strong> the three<br />
FA genes FANCI, FANCJ and FANCN . Besides FANCD2, FANCI is<br />
the second monoubiquitinated member <strong>of</strong> the FA/BRCA pathway . We<br />
show the biallelic mutations <strong>of</strong> four FA-I patients . The 5`-3`helicase<br />
BRIP1 and the BRCA2-binding protein PALB2 both act downstream<br />
<strong>of</strong> the monoubiquitination step and belong to the “group 3” proteins .<br />
We identified biallelic truncating BRIP1 mutations in eleven FA patients<br />
. In an additional seven FA patients we found biallelic PALB2<br />
mutations, designating PALB2 as FANCN . Interestingly, investigations<br />
<strong>of</strong> FANCJ and FANCN have shown that all known group 3 proteins<br />
(BRCA2/FANCD1, BRIP1/FANCJ, PALB2/FANCN) are breast cancer<br />
susceptibility genes . This recent emergence <strong>of</strong> new FA genes not only<br />
facilitated further understanding <strong>of</strong> a major DNA repair pathway, but<br />
also makes connections to tumorigenesis and cellular aging (Neveling<br />
et al ., Z Gerontol Geriatr 2007) .<br />
P04.145<br />
Role <strong>of</strong> Helicobacter Pylori in gastric adenocarcinoma : special<br />
emphasis on gender, androgen receptor and angiogenic factors<br />
S. Arbabi Bidgoli 1 , M. Djamali Zavarhei 2 , M. Soleimani 1 , S. Sajadi 1 ;<br />
1 Faculty <strong>of</strong> Pharmacy,Isalmic Azad University(IAU), Tehran, Islamic Republic <strong>of</strong><br />
Iran, 2 Department <strong>of</strong> Pathology,College <strong>of</strong> Medicine,Tehran University <strong>of</strong> Medical<br />
Sciences, Tehran, Islamic Republic <strong>of</strong> Iran.<br />
H. pylori increase the risk <strong>of</strong> gastric cancer which has higher incidence<br />
in men globally . Due to animal studies male gastric tissues respond<br />
more rapidly to H . pylori but the underlying roles <strong>of</strong> sex hormones and<br />
angiogenic factors remained unclear in both genders . We studied the<br />
roles <strong>of</strong> H pylori on tissue levels <strong>of</strong> Androgen Receptor (AR), uPA,<br />
MMP9 and TP as three major angiogenic and prognostic markers in<br />
gastric cancer . Malignant and non malignant tissues <strong>of</strong> 72 gastric adenocarcinoma<br />
cases who underwent surgery from 2004-2007 were<br />
analyzed by immunohistochemical methods . Higher prevalence <strong>of</strong> H<br />
pylori in males, lack <strong>of</strong> AR expression in normal cells <strong>of</strong> females and<br />
lower expression <strong>of</strong> AR in tumoral cells <strong>of</strong> females (p=0 .03) were the<br />
first significant differences between two genders. H pylori infection was<br />
evaluated as a relative risk factor <strong>of</strong> AR expression in males (OR=5)<br />
and females (OR=3) that means most <strong>of</strong> AR (+) tumors had history <strong>of</strong><br />
H .pylori infection in their normal cells . Although females showed higher<br />
uPA expression (p=0 .007) but H pylori negative tumors showed higher<br />
risk <strong>of</strong> tumoral uPA (OR=1 .13), MMP9 (OR=1 .24) and TP expression<br />
(OR=1 .12) in males . By recording the strong role <strong>of</strong> AR and h pylori<br />
infection on the expression <strong>of</strong> tumoral uPA and other angiogenic factors<br />
in women (OR=11 ) we concluded that H pylori plays inconsistent<br />
roles in two genders by inducing different unknown genes but AR plays<br />
similar roles in both genders by increasing the tissue levels <strong>of</strong> angiogenic<br />
factors .<br />
P04.146<br />
High frequency <strong>of</strong> mLH1 and msH2 mutations among familial<br />
gastric cancer patients<br />
A. S. Tsukanov1 , A. N. Loginova1 , N. I. Pospekhova1 , T. A. Muzaffarova1 , L. N.<br />
Lubchenko2 , M. P. Nikulin2 , A. V. Karpukhin1 ;<br />
1 2 Research Centre For Medical <strong>Genetics</strong>, Moskow, Russian Federation, Cancer<br />
Research Centre, Moskow, Russian Federation.<br />
Mutations <strong>of</strong> CDH1 gene are associated with familial diffuse gastric<br />
cancer . MLH1 and MSH2 mutations are associated generally with hereditary<br />
non-polyposis colon cancer syndrome that may include gastric<br />
cancer . So MLH1 and MSH2 mutations predispose to gastric cancer .<br />
However a frequency <strong>of</strong> MLH1 and MSH2 mutations among patients<br />
with familial gastric cancer unselected on cancer type or familial history<br />
is unknown .<br />
We investigated the sample <strong>of</strong> 30 patients with familial gastric cancer<br />
on mutations <strong>of</strong> CDH1, MLH1 and MSH2 genes . The structure <strong>of</strong> our<br />
sample was near to a distribution <strong>of</strong> different familial gastric cancer<br />
types in the population and includes 8 families with diffuse gastric<br />
cancer . There were 5 germline MLH1 and MSH2 mutations among 30<br />
patients (16,6%) . Mutations have been found in families with gastric<br />
cancer only as well as in the families with both gastric and colon can-<br />
cer cases . There were no mutations in CDH1 gene . Thus, a frequency<br />
<strong>of</strong> MLH1/MSH2 mutations associated with familial gastric cancer is<br />
higher in comparison with the CDH1 gene mutations (P=0,026) .<br />
P04.147<br />
telomere function in giant cell tumors <strong>of</strong> bone<br />
S. Gebre-Medhin1 , Y. Jin1 , T. Jonson1 , K. Broberg2 , N. Mandahl1 , F. Mertens1 ;<br />
1 2 Department <strong>of</strong> clinical genetics, University hospital, Lund, Sweden, Department<br />
<strong>of</strong> occupational medicine, University hospital, Lund, Sweden.<br />
BACKGROUND: Giant cell tumor <strong>of</strong> bone (GCT) is a locally aggressive<br />
tumor accounting for 1/20 <strong>of</strong> all bone tumors . Morphologically, GCTs<br />
show osteoclast-like giant cells mixed with mononuclear putative neoplastic<br />
cells . Cytogenetically, GCTs <strong>of</strong>ten show telomeric associations<br />
(tas) paralleled by an otherwise normal karyotype . It remains to be<br />
established whether tas in GCT represent deregulation <strong>of</strong> cis-regulatory<br />
or trans-regulatory mechanisms at the telomere, or a combination<br />
there<strong>of</strong>, or are caused by other yet unknown mechanisms .<br />
METHODS: DNA was extracted from fresh frozen biopsies <strong>of</strong> 20 GCTs<br />
for telomere length analysis . From the same 20 cases, RNA was extracted<br />
for quantitative RT-PCR analysis concerning the expression<br />
levels <strong>of</strong> four genes (TERT, TRF1, TRF2 and POT1) involved in telomere<br />
function . FISH analysis was performed to evaluate the frequency<br />
<strong>of</strong> telomere-negative chromosome ends .<br />
RESULTS: No correlation between presence <strong>of</strong> clonal chromosome<br />
aberrations and telomere length in tumor cells could be detected . At<br />
FISH analysis there was a correlation between frequency <strong>of</strong> tas and<br />
number <strong>of</strong> telomere-negative chromosome ends . Expression <strong>of</strong> TERT,<br />
TRF1, TRF2 and POT1 was found in all tumors . Analysis regarding the<br />
correlation between expression levels <strong>of</strong> individual genes and cytogenetic<br />
and clinical features is ongoing .<br />
CONCLUSION: In view <strong>of</strong> our preliminary data, it is unlikely that the<br />
high frequency <strong>of</strong> tas could be explained by altered expression levels<br />
<strong>of</strong> any <strong>of</strong> the investigated genes . However, it can not be ruled out that<br />
altered function at the protein level <strong>of</strong> TERT, TRF1, TRF2 or POT1 is<br />
involved in tas formation .<br />
P04.148<br />
Overexpression <strong>of</strong> wild-type p53 suppresses Cathepsin B<br />
(CSTB) in glioblastoma cells<br />
M. Heidari, M. Safari, O. Seyedi;<br />
Tehran University/Medical Sciences, Tehran, Islamic Republic <strong>of</strong> Iran.<br />
The tumor suppressor protein p53 plays critical role in modulating cellular<br />
functions such as cell cycle arrest and apoptosis . Due to its function<br />
in growth inhibition as well as contribution <strong>of</strong> its mutated form in >50%<br />
<strong>of</strong> human tumors particularly a significant proportion <strong>of</strong> glioma cases,<br />
p53 is considered a fundamental tumour suppressor gene . In order to<br />
investigate potential p53 target gene(s), we employed overexpression<br />
<strong>of</strong> wild-type p53 via recombinant adenovirus (Ad-GFP-P53) which encodes<br />
green fluorescent protein and p53 separately, and cDNA AFLP<br />
approaches in U87 glioblastoma cells . In response to overexpression<br />
<strong>of</strong> wild-type p53, cDNA AFLP results revealed the suppression <strong>of</strong> cathepsin<br />
B (CSTB) gene which encodes a protease but not in infected<br />
cells with Ad-GFP which does not express p53 and mock control .<br />
Semi-quantitative RT-PCR analysis confirmed the activation <strong>of</strong> CTSB<br />
gene in cells containing Ad-GFP and mock control however; its transcriptional<br />
activity was suppressed in infected cells with Ad-GFP-P53 .<br />
In addition, computational analysis detected several potential p53 DNA<br />
target sequences within introns <strong>of</strong> CTSB genes . Taken together our<br />
results suggested that CTSB gene might be directly regulated by p53<br />
protein as a transcription regulatory protein in glioblastoma .<br />
P04.149<br />
mGmt and p15 promotor methylation - prognostic parameters<br />
for TMZ chemotherapy response?<br />
S. Wemmert 1 , R. Ketter 1 , M. Bettscheider 1 , S. Alt 2 , K. Kammers 3 , J. Rahnenführer<br />
3 , W. Steudel 1 , S. Urbschat 1 ;<br />
1 Department <strong>of</strong> Neurosurgery, Saarland University, Homburg, Germany, 2 Institute<br />
<strong>of</strong> Immunology, National Public Health Laboratory, Luxembourg, Luxembourg,<br />
3 Department <strong>of</strong> Statistics, Technical University Dortmund, Dortmund,<br />
Germany.<br />
Glioblastomas are the most frequent and malignant brain tumors in<br />
adults . Surgical cure is virtually impossible and despite <strong>of</strong> radiation and<br />
chemotherapy the clinical course is very poor . Epigenetic silencing <strong>of</strong>